TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

FDA approval progress: Want news, and dates.EU trials: good...

  1. Lionel
    300 Posts.
    clock Created with Sketch.
    15/07/11
    14:59
    Post #: 8681308
    FDA approval progress: Want news, and dates.
    EU trials: good clinical news, as usual. What about regulators' opinions? Don't want a surprise PXS.

    Management: Probably better at biology than communications. But, I'd definitely prefer it like that than the inverse.
    TIS Price at posting: 55.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.